Noam E. Kopmar, MD

/content/dam/www/faculty-photos/K/noam-kopmar/noam-kopmar.jpg
Dr. Noam E. Kopmar MD
FACULTY MEMBER

Noam E. Kopmar, MD

Assistant Professor, Clinical Research Division, Fred Hutch

Assistant Professor
Clinical Research Division, Fred Hutch

Dr. Noam Kopmar is a hematologist-oncologist and clinician-researcher focusing on blood and marrow transplantation, cellular immunotherapy, leukemia and lymphoma. A graduate of Ben-Gurion University of the Negev, Dr. Kopmar completed a residency in internal medicine at the University of Washington School of Medicine and a fellowship in hematology-oncology at the University of Washington School of Medicine/Fred Hutch Cancer Center. 

In 2023, Dr. Kopmar received the American Society of Clinical Oncology Conquer Cancer Merit Award for his work on frontline therapy to treat patients with relapsed or refractory B-cell acute lymphoblastic leukemia or lymphoma. He is board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine.

Other Appointments & Affiliations

Physician, Fred Hutch

Physician
Fred Hutch

Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine

Assistant Professor
Division of Hematology and Oncology, University of Washington School of Medicine

Education

Fellowship, Hematology and Medical Oncology, University of Washington/Fred Hutch, 2023

Residency, Internal Medicine, University of Washington, 2018

MD, Ben Gurion University, 2015

BS, University of California Santa Cruz, 2008

Diseases Researched

Acute lymphoblastic leukemia

Acute myeloid leukemia

Amyloidosis

Blood disorders

Chronic lymphocytic leukemia

Chronic myeloid leukemia

Leukemia

Lymphoma

Multiple myeloma

Myelodysplastic syndrome

Myeloproliferative neoplasms

Non-Hodgkin lymphoma

Research Focus

Clinical trials and clinical outcomes research in hematologic malignancies with a particular focus on acute leukemias

Clinical Expertise

Acute leukemia

Blood and marrow transplantation

Cellular immunotherapy

Board Certification

Hematology, 2023; Medical Oncology; 2023 Internal Medicine, 2019; American Board of Internal Medicine